JY
DMAQR

Jeff Yass’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Jeff Yass’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,749
Closed -$1K – 14110
2022
Q3 		$1K Sell
16,749
-26,801
-62% -$2.96K ﹤0.01% 13009
2022
Q2 		$5K Buy
+43,550
New +$7.09K ﹤0.01% 12609
2022
Q1 		– Sell
-15,124
Closed -$5K – 14258
2021
Q4 		$5K Buy
+15,124
New +$4.78K ﹤0.01% 12991

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 14.02% 1-Year Est. Return

Jeff Yass's DMAQR Position: Q4 2022 in Review

Jeff Yass sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q4 2022, closing a stake of 16,749 shares — an estimated $1K sold.

Jeff Yass first reported a position in DMAQR in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q2 2022. 29 funds tracked by Wall St. Rank hold DMAQR as of Q4 2022.

  • Jeff Yass reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 16,749 Deep Medicine Acquisition Corp. Rights shares in Q4 2022, an estimated $1K.
  • Jeff Yass first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 3 quarters.
  • Jeff Yass's Deep Medicine Acquisition Corp. Rights position peaked at $5K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.